Compare Amylx Pharmaceuticals Inc (AMLX) vs Enbridge Inc (ENB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Enbridge Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Enbridge Inc trades at $51.97 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 42.7× Amylx Pharmaceuticals Inc's market cap, and Enbridge Inc pays a 5.34% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | ENB | |
|---|---|---|
Market Cap | $2.64B | $112.62B |
Sector | Health | Energy |
52-Week High | $24.19 | $58.04 |
52-Week Low | $7.82 | $45.23 |
Enterprise Value | $2.39B | $196.53B |
Dividend Yield | — | 5.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →
